drugset / Trial / NCT02189330

A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples

NCT02189330

Phase 1 Completed 24 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

All subjects in this study will be given tafamidis. After swallowing a single pill of tafamidis, measurements including blood samples will be compared to see if tafamidis made in different ways is about the same. After approximately 28 days subjects will be given another pill of tafamidis and the study measurements will be repeated.

Timeline

Start
2014-05
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tafamidis Unknown 12.2 mg Oral
Subject Tafamidis Unknown 20 mg Oral

Indications

No indication recorded.